FNY Investment Advisers’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,730
Closed -$170K 516
2020
Q1
$170K Buy
+2,730
New +$249K 0.13% 129
2019
Q1
Sell
-1,500
Closed -$187K 841
2018
Q4
$187K Buy
+1,500
New +$257K 0.07% 131
2018
Q3
Sell
-20
Closed -$4.05K 1144
2018
Q2
$3K Buy
+20
New +$2.56K ﹤0.01% 720

Other funds holding MED

FNY Investment Advisers's MED Position: Q2 2020 in Review

FNY Investment Advisers sold out of Medifast (MED) in Q2 2020, closing a stake of 2,730 shares — an estimated $170K sold.

FNY Investment Advisers first reported a position in MED in Q2 2018 and held it in 3 quarters. The position peaked at $187K in Q4 2018. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

  • FNY Investment Advisers reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 2,730 Medifast shares in Q2 2020, an estimated $170K.
  • FNY Investment Advisers first reported a position in Medifast in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Medifast position peaked at $187K in Q4 2018.
  • 224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on FNY Investment Advisers's 13F filing for Q2 2020, filed 10 Jul 2020.